CHMP Positive On Pfizer's Adalimumab
As Accord Gets Nods For Azacitidine And Dexmedetomidine
Pfizer’s Amsparity biosimilar adalimumab has been endorsed by the EMA’s CHMP as a rival to Humira. At the same time, Accord has received positive opinions for generic azacitidine and dexmedetomidine.
